131 related articles for article (PubMed ID: 25522242)
1. Identification of c-MYC SUMOylation by mass spectrometry.
Kalkat M; Chan PK; Wasylishen AR; Srikumar T; Kim SS; Ponzielli R; Bazett-Jones DP; Raught B; Penn LZ
PLoS One; 2014; 9(12):e115337. PubMed ID: 25522242
[TBL] [Abstract][Full Text] [Related]
2. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
3. PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
Rabellino A; Melegari M; Tompkins VS; Chen W; Van Ness BG; Teruya-Feldstein J; Conacci-Sorrell M; Janz S; Scaglioni PP
Cell Rep; 2016 Jun; 15(10):2266-2278. PubMed ID: 27239040
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC
Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903
[TBL] [Abstract][Full Text] [Related]
5. Melatonin disturbs SUMOylation-mediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells.
Lee H; Lee HJ; Jung JH; Shin EA; Kim SH
J Pineal Res; 2018 Sep; 65(2):e12496. PubMed ID: 29654697
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation of Myc-family proteins.
Sabò A; Doni M; Amati B
PLoS One; 2014; 9(3):e91072. PubMed ID: 24608896
[TBL] [Abstract][Full Text] [Related]
7. Detection of Post-translational Modifications on MYC.
Daniel CJ; Sun XX; Chen Y; Zhang X; Dai MS; Sears RC
Methods Mol Biol; 2021; 2318():69-85. PubMed ID: 34019287
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
9. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems.
Pescarolo MP; Bagnasco L; Malacarne D; Melchiori A; Valente P; Millo E; Bruno S; Basso S; Parodi S
FASEB J; 2001 Jan; 15(1):31-33. PubMed ID: 11099487
[TBL] [Abstract][Full Text] [Related]
10. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
11. TRIM6 interacts with Myc and maintains the pluripotency of mouse embryonic stem cells.
Sato T; Okumura F; Ariga T; Hatakeyama S
J Cell Sci; 2012 Mar; 125(Pt 6):1544-55. PubMed ID: 22328504
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
13. Merlin sumoylation is required for its tumor suppressor activity.
Qi Q; Liu X; Brat DJ; Ye K
Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
[TBL] [Abstract][Full Text] [Related]
14. MYC phosphorylation at novel regulatory regions suppresses transforming activity.
Wasylishen AR; Chan-Seng-Yue M; Bros C; Dingar D; Tu WB; Kalkat M; Chan PK; Mullen PJ; Huang L; Meyer N; Raught B; Boutros PC; Penn LZ
Cancer Res; 2013 Nov; 73(21):6504-15. PubMed ID: 24030976
[TBL] [Abstract][Full Text] [Related]
15. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
17. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
18. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
Bubman D; Guasparri I; Cesarman E
Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
[TBL] [Abstract][Full Text] [Related]
20. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
